XAIR
Medical Devices · Healthcare
CEO
Equibles does not estimate personal net worth.
Earlier roles on record: CEO at Beyond Air, Inc. (XAIR) until March 27, 2026. Beyond Air, Inc. reported in an 8-K filed April 1, 2026 that Steve Lisi resigned as Board of Directors, effective March 27, 2026. Beyond Air, Inc. reported in an 8-K filed April 1, 2026 that Steve Lisi resigned as Chief Executive Officer, effective March 27, 2026. Steve Lisi has spoken on 20 earnings calls across 1 company, most recently for Beyond Air, Inc. on February 13, 2026. The companies whose calls Steve Lisi spoke on are classified in the Healthcare sector.
“Steve Lisi has resigned as Chief Executive Officer and stepped down from the Board of Directors, effective March 27, 2026, to pursue other opportunities.”
“Steve Lisi has resigned as Chief Executive Officer and stepped down from the Board of Directors, effective March 27, 2026, to pursue other opportunities.”
“With me here today is Dan Moorhead, our new Chief Financial Officer. It has been a pleasure working with Dan over the past several months. He brings a proven track record as a proactive CFO with demonstrated success supporting commercial organizations through periods of rapid growth.”
“With me here today is Doug Larson, our Chief Financial Officer. Let's start today's call by stating how pleased we are with the sequential quarterly revenue growth we are seeing as our commercial team continues to make significant progress.”
“With me here today is Larson Larson, our Chief Financial Officer. I'm excited to report that the Beyond Air team is successfully executing our commercial strategy and building positive momentum.”
“Joining me on the call is Doug Larson, Chief Financial Officer, and we're both happy to be here today.”
“Today, we announced a strong step in the right direction with a greater than 60% increase in revenue this quarter versus last quarter. While this is a small number in absolute terms, there are several factors that give us confidence in hitting our fiscal year 2025 revenue guidance of $12 million to $16 million.”
Start not stated–2026-03-27
XAIR
Medical Devices · Healthcare
CEO